Minerva Neurosciences
NERV
NERV
23 hedge funds and large institutions have $7.51M invested in Minerva Neurosciences in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
54% less capital invested
Capital invested by funds: $16.3M → $7.51M (-$8.83M)
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Holders
23
Holding in Top 10
–
Calls
$311K
Puts
$189K
Top Buyers
| 1 | +$28K | |
| 2 | +$19K | |
| 3 | +$11.2K | |
| 4 |
Citigroup
New York
|
+$7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.36K |
Top Sellers
| 1 | -$850K | |
| 2 | -$76K | |
| 3 | -$62.6K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$54K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$47K |